Replies to post #3314 on Atossa Therapeutics Inc (ATOS)

[XenaLives]

(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2023-00701&r=1